Recognition of Natural Products as Potential Inhibitors of COVID‑19 Main Protease (Mpro): In‑Silico Evidences SD Narkhede, R.R., Pise, A.V., Cheke, R.S., Shinde Natural Products and Bioprospecting, 2020 | 201 | 2020 |
The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2 RR Narkhede, RS Cheke, JP Ambhore, SD Shinde Eurasian Journal of Medicine and Oncology 4 (3), 185-195, 2020 | 139 | 2020 |
Therapeutic outcomes of isatin and its derivatives against multiple diseases: Recent developments in drug discovery RS Cheke, VM Patil, SD Firke, JP Ambhore, IA Ansari, HM Patel, ... Pharmaceuticals 15 (3), 272, 2022 | 43 | 2022 |
Molecular insights into coumarin analogues as antimicrobial agents: Recent developments in drug discovery RS Cheke, HM Patel, VM Patil, IA Ansari, JP Ambhore, SD Shinde, ... Antibiotics 11 (5), 566, 2022 | 30 | 2022 |
Coronavirus: Hotspot on coronavirus disease 2019 in India DC Rameshwar S. Cheke , Sachin Shinde, Jaya Ambhore, Vaibhav Adhao Indian Journal of Medical Sciences 72 (1), 29-34, 2020 | 25 | 2020 |
Isatin: New hope against convulsion RS Cheke, SD Firke, RR Patil, SB Bari Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2018 | 24 | 2018 |
Recent advances in pharmacological diversification of Src family kinase inhibitors P Negi, RS Cheke, VM Patil Egyptian Journal of Medical Human Genetics 22, 1-16, 2021 | 18 | 2021 |
Quinazoline: An update on current status against convulsions RS Cheke, SD Shinde, JP Ambhore, SR Chaudhari, SB Bari Journal of Molecular Structure 1248, 131384, 2022 | 16 | 2022 |
Natural product emerging as potential SARS spike glycoproteins-ACE2 inhibitors to combat COVID-19 attributed by in-silico investigations RS Cheke, RR Narkhede, SD Shinde, JP Ambhore, PG Jain Biointerface Res. Appl. Chem 11, 10628-10639, 2021 | 16 | 2021 |
Discovery and Anticancer Activity of Novel 1,3,4-Thiadiazole- and Aziridine-Based Indolin-2-ones via In Silico Design Followed by Supramolecular Green Synthesis PJ Chaudhari, SB Bari, SJ Surana, AA Shirkhedkar, CG Bonde, ... ACS omega 7 (20), 17270-17294, 2022 | 13 | 2022 |
Futuristic review on progress in force degradation studies and stability indicating assay method for some antiviral drugs JP Ambhore, VS Adhao, RS Cheke, RR Popat, SJ Gandhi GSC Biological and Pharmaceutical Sciences 16 (1), 133-149, 2021 | 13 | 2021 |
Abrogation of cisplatin-induced nephrotoxicity in rats and HEK-293 cell lines by formononetin: in vivo and in vitro study SD Shinde, PG Jain, RS Cheke, SJ Surana, SM Gunjegaonkar Comparative Clinical Pathology 30 (4), 617-625, 2021 | 12 | 2021 |
The Berberis aristata Ameliorates oxazolone induced contact dermatitis: in-vivo and in silico evidences SD Shinde, RS Cheke, PR Tathe, PG Jain, RR Narkhede Advances in Traditional Medicine 21, 685-692, 2021 | 9 | 2021 |
A concise analytical profile of efavirenz: analytical methodologies JP Ambhore, SR Chaudhari, RS Cheke, PS Kharkar Critical Reviews in Analytical Chemistry 52 (7), 1583-1592, 2022 | 8 | 2022 |
Reverse phase-liquid chromatography assisted protocol for simultaneous determination of lamivudine and tenofovir disoproxil fumarate in combined medication used to control HIV … VS Adhao, SR Chaudhari, JP Ambhore, S Sangolkar, RR Thenge, ... Future Journal of Pharmaceutical Sciences 7, 1-11, 2021 | 8 | 2021 |
Recognition of natural products as potential inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences. Nat Prod Bioprospect. 2020; 10 (5): 297–306 RR Narkhede, AV Pise, RS Cheke, SD Shinde doi. org/10.1007/s13659-020-00253-1, 0 | 7 | |
Rationale design, synthesis, and pharmacological evaluation of isatin analogues as antiseizure agents S Firke, R Cheke, V Ugale, S Khadse, M Gagarani, S Bari, S Surana Letters in Drug Design & Discovery 18 (12), 1146-1164, 2021 | 6 | 2021 |
Molecular insights into resveratrol and its analogs as SARS-CoV-2 (COVID-19) protease inhibitors VM Patil, RR Narkhede, N Masand, RS Cheke, K Balasubramanian Coronaviruses 2 (11), 11-29, 2021 | 6 | 2021 |
Understanding the dynamics of COVID-19 outbreak: Structure, diagnosis, prevention and treatment RR Narkhede, RS Cheke, SD Shinde, VG Kuchake, NM Mahajan, ... Anti-Infective Agents 19 (4), 3-14, 2021 | 3 | 2021 |
Repurposing of anthelmintic drugs against SARS-CoV-2 (Mpro and RdRp): novel disease, older therapeutics RS Cheke, RR Narkhede, SD Shinde, JP Ambhore, PG Jain Letters in Applied NanoBioScience 10 (2), 2331-2338, 2020 | 3 | 2020 |